NASDAQ: DXCM       Dexcom
Last Price Today's Change   Day's Range   Trading Volume
366.74   +2.62 (0.72%)  357.96 - 368.184  304,599


Avg Volume (4 weeks):970,770
4 Weeks Range:347.59 - 396.98
4 Weeks Price Volatility (%):
52 Weeks Range:182.07 - 456.23
52 Weeks Price Volatility (%):
Average Price Target: 48.00
Price Target Upside/Downside: -318.74


No recent Headlines for this stock.

Business Background

Dexcom, Inc. (Dexcom) is a medical device company. The Company is focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for ambulatory use by people with diabetes and for use by healthcare providers. The Company's products consist of DexCom G4 PLATINUM and DexCom G5 Mobile. The Company is commercializing its fifth generation CGM system. The Company's markets DexCom G4 PLATINUM under a Conformite Europeenne Marking (CE Mark), in the European Union, Australia, New Zealand and the countries in Asia and Latin America, and in the United States with approval from the United States Food and Drug Administration (FDA). The DexCom G4 PLATINUM with Share remote monitoring system uses a wireless connection between a patient's receiver and an application on the patient's iPhone, iPod touch, or iPad to transmit glucose information to applications on the mobile devices of designated recipients (followers).

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

2039  4348  261  3253 

Top 10 Active Counters
 NAKD 0.487+0.051 
 F 11.775+0.915 
 CTRM 0.396+0.071 
 ACST 0.835+0.079 
 BBIG 6.198+4.658 
 LK 1.38+1.38 
 CLSN 1.77+0.495 
 ADTX 4.46+1.85 
 WPX 9.43+0.48 
 SNDL 0.656-0.025